rejuvant life tabs

Muhdo & ARK-KCL collaborate on consumer epigenetic tests

Latest articles

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...
Rejuvant

Muhdo partner with King’s College London in an advanced research project around epigenetics, AI and informatics.

Muhdo has announced it will be partnering with Ageing Research at King’s College London (ARK) on collaborative research around health, lifestyle through innovative data sciences.

Longevity.Technology: Epigenetic tests – identifying and mitigating the health challenges and predispositions of the individual – is big news. Last year we covered Muhdo‘s collaboration with My PT Hub to bring the benefits of DNA and epigenetic testing to the world of personal training and this new collaboration will focus on how AI can help people to better understand the value of health and lifestyle data, for both end consumers and those researching healthy longevity.

The gap between life and health expectancy is growing larger every year. Our health and lifestyle needs are also changing, and more research is required to reduce the risk of preventable aging-related diseases to improve physical and mental wellbeing throughout the life course.

We might be living longer, but unfortunately not as healthily as we should; numbers of multiple long-term conditions like asthma, diabetes, obesity and heart disease are on the rise, and patients with multiple long term conditions are becoming the norm rather than the exception. However, it is estimated that around 75% of health and life expectancy after the age of 40 is modifiable.

Muhdo is pioneering epigenetics testing in the workplace and community, with the goal of helping people understand our biological age and better predicting their future health, bridging the gap between consumer wellness and technology. This will allow people to be more proactive in helping to manage their health and wellbeing through lifestyle changes.

Together with ARK-affiliated academics and healthcare professionals, as well as industry partners, Muhdo aims to develop the next generation of consumer epigenetics testing integrated with other biomarkers of lifestyle and environmental data through AI and advanced data analytics. In particular, Svitlana Surodina, ARK’s new Entrepreneur in Residence and researcher in the Department of Informatics at King’s, will be developing novel technologies for integrating with Muhdo’s platform.

In addition, Muhdo says it is “extremely pleased” to be working closely with Dr Richard Siow, ARK Director, who will be joining Muhdo’s Scientific Advisory Board.

Elevant

Richard Siow: Director of Ageing Research, KCL
Richard Siow: Director of Ageing Research, KCL

Siow’s research focuses on nutrigenomics for healthy longevity and the mechanisms of aging. He has published extensively in leading biomedical journals and is the UK Lead for the International Society on Ageing and Disease. He is an Associate Editor of Frontiers in Genetics and Frontiers in Nutrition and a member of the Advisory Board of the UK All Party Parliamentary Group for Longevity and The Lancet Healthy Longevity.

Nathan Berkley, CEO of Muhdo, said: “We at Muhdo are very excited to be partnering with one of the most respected universities in this field and carry out this cutting-edge research looking at health and wellbeing data and the value it can provide to everyone in terms of looking after their own wellbeing.

“DNA and epigenetics have the capability to help everyone at every stage of life to reach their full health potential. We believe this is a true milestone in the global application of epigenetics [1].”

Richard Siow, Director of ARK, commented: “We’re always searching for novel ways to push the boundaries of our research in applying the scientific breakthroughs to the real-world problems and partnering with market leaders to deliver a major impact on people’s lives and society at large. We are delighted to start this cooperation with Muhdo which will apply the data science and AI innovations to improve global health and longevity [1].”

Elevant

[1] https://prn.to/3dHbjKs

Image credits: Nathan Berkley / Muhdo and Dr Richard Siow / ARK

Comment on this article

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

FOXO exclusively licenses epigenetic clocks from UCLA

FOXO Technologies' exclusive licence of epigenetic clocks PhenoAge and GrimAge from UCLA could be an insurance game-changer. FOXO Technologies Inc has announced the licence of...

Cellino: longevity powered by AI, stem cells & democracy

From a serendipitous meeting of minds to laser-enabled precision, Cellino is leveraging AI and pluripotent stem cells for longevity. We speak to CEO and...

AXA and Microsoft launch one-stop digital health platform

Microsoft joins forces with AXA for ‘one-stop’ digital healthcare platform. One of Europe's leading insurance companies AXA has announced it has formed a partnership with...

Tectonic Therapeutic launches with $80m series A

To drug the 'undruggable' – Tectonic's series A financing to transform the discovery of novel G-protein coupled receptor (GPCR)-targeted therapies is co-led by Vida...
Supps report ad middle